Annexin VII as a novel marker for invasive phenotype of malignant melanoma

Japanese Journal of Cancer Research

Volumn 91, Issue 1, 2000, Pages 75-83

  Kataoka, Tatsuki R ^a   Akihiko, Ito ^a   Asada, Hideo ^a   Watabe, Kenji ^b   Nishiyama, Kazutaka ^b   Nakamoto, Ken'i ^b   Itami, Satoshi ^a   Yoshikawa, Kunihiko ^a   Ito, Masaki ^c   Nojima, Hiroshi ^b   Kitamura, Yukihiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

B16 melanoma; Ca2+ binding protein; Fusion cells; Immunohistochemistry

Indexed keywords

ANTIBODY; MESSENGER RNA; SYNEXIN; TUMOR MARKER;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAST CELL; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0342546414     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00862.x     Document Type: Article

References (35)

1. Ostmeier, H., Fuchs, B., Otto, F., Mawick, R., Lippold, A., Krieg, V. and Suter, L. Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma? Cancer, 85, 2391-2399 (1999).
2. Straume, O. and Akslen, L. A. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int. J. Cancer, 74, 535-539 (1997).
3. van der Oord, J. J., Maes, A., Stas, M., Nuyts, J., Battocchio, S., Kasran, A., Garmyn, M., De Wever, I. and DeWolf-Peeters, C. CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am. J. Pathol., 149, 1953-1961 (1996).
4. Tsao, H., Zhang X., Benoit, E. and Haluska, F. G. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene, 16, 3397-3402 (1998).
5. Shin, M. S., Park, W. S., Kim, S. Y., Kim, H. S., Kang, S. J., Song, K. Y., Park, J. Y., Dong, S. M., Pi, J. H., Oh, R. R., Lee, J. Y., Yoo, N. J. and Lee, S. H. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma. Am. J. Pathol., 154, 1785-1791 (1999).
6. Kelley, M. C., Jones, R. C., Gupta, R. K., Yee, R., Stern, S., Wanek, L. and Morton, D. L. Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma. Cancer, 83, 1355-1361 (1998).
7. Bosserhoff, A. K., Kaufmann, M., Kaufmann, B., Bartke, I., Zirngibl, H., Hein, R., Stolz, W. and Buettner, R. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res., 57, 3149-3153 (1997).
8. Abraha, H. D., Fuller, L. C., Du Vivier, A. W., Higgins, E. M. and Sherwood, R. A. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. Br. J. Dermatol., 137, 381-385 (1997).
9. Nakaji, T., Kataoka, T. R., Watabe, K., Nishiyama, K., Nojima, H., Shimada, Y., Sato, F., Matsushima, H., Endo, Y., Kuroda, Y., Kitamura, Y., Ito, A. and Maeda, S. A new member of the GTPase superfamily that is upregulated in highly metastatic cells. Cancer Lett. (1999), in press.
10. Fidler, I. J. Selection of successive tumour lines for metastasis. Nature, 242, 148-149 (1973).
11. Hart, I. R. The selection and characterization of an invasive variant of the B16 melanoma. Am. J. Pathol., 97, 587-600 (1979).
12. Poste, G., Doll, J., Hart, I. R. and Fidler, I. J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res., 40, 1636-1644 (1980).
13. Ito, M., Izuhara, M., Shimizu, K. and Sekiguchi, M. Metastatic phenotype in hybrid cells derived from B16 melanoma. Cancer Lett., 78, 33-36 (1994).
14. Ohashi, M., Aizawa, S., Ooka, H., Ohsawa, T., Kaji, K., Kondo, H., Kobayashi, T., Noumura, T., Matsuo, M., Mitsui, Y., Murota, S., Yamamoto, K., Ito, H., Shimada, H. and Utakoji, T. A new human diploid cell strain. TIG-1, for the research on cellular aging. Exp. Gerontol., 15, 121-133 (1980).
15. Ito, A., Morii, E., Maeyama, K., Jippo, T., Kim, D. K., Lee, Y. M., Ogihara, H., Hashimoto, K., Kitamura, Y. and Nojima, H. Systematic method to obtain novel genes that are regulated by mi transcription factor: impaired expression of granzyme B and tryptophan hydroxylase in mi/mi cultured mast cells. Blood, 91, 3210-3221 (1998).
16. Hoshino, A., Hisayasu, S. and Shimada, T. Complete sequence analysis of rat transferrin and expression of transferrin but not lactoferrin in the digestive glands. Comp. Biochem. Physiol. Biochem. Mol. Biol., 113, 491-497 (1996).
17. Segade, F., Claudio, E., Wrobel, K., Ramos, S. and Lazo, P. S. Isolation of nine gene sequences induced by silica in murine macrophages. J. Immunol., 154, 2384-2392 (1995).
18. Zhang-Keck, Z.-Y., Burns, A. L. and Pollard, H. B. Mouse synexin (annexin VII) polymorphisms and a phylogenetic comparison with other synexins. Biochem. J., 289, 735-741 (1993).
19. Sugimoto, Y., Oh-hara, T., Watanabe, M., Saito, H., Yamori, T. and Tsuruo, T. Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential. Cancer Res., 47, 4396-4401 (1987).
20. Burns, A. L., Magendzo, K., Shirvan, A., Srivastava, M., Rojas, E., Alijani, M. R. and Pollard, H. B. Calcium channel activity of purified human synexin and structure of the human synexin gene. Proc. Natl. Acad. Sci. USA, 86, 3798-3802 (1989).
21. Shirvan, A., Srivastava, M., Wang, M. G., Cultraro, C., Magendzo, K., McBride, O. W., Pollard, H. B. and Burns, A. L. Divergent structure of the human synexin (annexin VII) gene and assignment to chromosome 10. Biochemistry, 33, 6888-6901 (1994).
22. Selbert, S., Fischer, P., Pongratz, D., Stewart, M. and Noegel, A. A. Expression and localization of annexin VII (synexin) in muscle cells. J. Cell Sci., 108, 85-95 (1995).
23. UICC. "TMN Classification of Malignant Tumors," 4th Ed., pp. 83-91 (1987). Springer-Verlag, Berlin.
24. Clark, W. H., From, L., Bernardino, E. A. and Mihm, M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res., 29, 705-720 (1969).
25. Ishiguro, T., Nakajima, M., Naito, M., Muto, T. and Tsuruo, T. Identification of genes differentially expressed in B16 murine melanoma sublines with different inetastatic potentials. Cancer Res., 56, 875-879 (1996).
26. Raynal, P. and Pollard, H. B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins. Biochim. Biophys. Acta. 1197, 63-93 (1994).
27. Creutz, C. E., Pazoles, C. J. and Pollard, H. B. Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules. J. Biol. Chem., 253, 2858-2866 (1978).
28. Creutz, C. E., Pazoles, C. J. and Pollard, H. B. Self-association of synexin in the presence of calcium. Correlation with synexin-induced membrane fusion and examination of the structure of synexin aggregates. J. Biol. Chem., 254, 553-558 (1979).
29. Creutz, C. E. cis-Unsaturated fatty acids induce the fusion of chromaffin granules aggregated by synexin. J. Cell Biol., 91, 247-256 (1981).
30. Creutz, C. E. The annexins and exocytosis. Science, 258, 924-931 (1992).
31. Pollard, H. B., Burns, A. L. and Rojas, E. Synexin (annexin VII): a cytosolic calcium-binding protein which promotes membrane fusion and forms calcium channels in artificial bilayer and natural membranes. J. Membr. Biol., 117, 101-112 (1990).
32. Pollard, H. B., Rojas, E., Pastor, R. W., Rojas, E. M., Guy, H. R. and Burns, A.L. Synexin: molecular mechanism of calcium-dependent membrane fusion and voltage-dependent calcium-channel activity. Evidence in support of the "hydrophohic bridge hypothesis" for exocytotic membrane fusion. Ann. NY Acad. Sci., 635, 328-351 (1991).
33. Balch, C. and Dedman, J. R. Annexins II and V inhibit cell migration. Exp. Cell Res., 237, 259-263 (1997).
34. Theobald, J., Hanby, A., Patel, K. and Moss, S. E. Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells. Br. J. Cancer, 71, 786-788 (1995).
35. Francia, G., Mitchell, S. D., Moss, S. E., Hanby, A. M., Marshall, J. F. and Hart, I. R. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res., 56, 3855-3858 (1996).